US$ 26.92
anthem glp 1 coverage 2025 Does Cover Zepbound for Weight Loss? Employers Take a Variety of
Description
Novo Nordisk has asked the FDA to block compounders from making versions of its older, once-daily GLP-1 agonist liraglutide.

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.

are the major companies operating in this market.
Outcomes included changes in left ventricular ejection fraction (LVEF), end-diastolic volume (LVEDV), end-systolic volume (LVESV), global longitudinal strain (GLS), left ventricular mass, left atrial volume (LAV), and NT-proBNP levels

95% CI 0.90, 1.01) and cerebrovascular events (HR 0.99
